Category: Pharma & drug development
Intellectual property in the time of COVID-19
Could nanoparticles unlock the pharmaceutical benefits of turmeric?
Finding a cure for HIV with ViiV Healthcare
Peptomyc: the quest for a universal cancer treatment
What does ‘ageing’ mean when it comes to drug development?
Sky high: should US drugs prices fall in line with the rest of the world?
The rise of fake medicines in Africa
Q&A: Gavi alliance talks immunising 300 million people
Recurrent miscarriage: could this devastating condition have a simple cure?
A safer ride: the latest innovation in targeted cancer treatment
The problem of manipulated data
Why is pharma so bad at sharing clinical trial information?
Q&A: an eye on innovation with SparingVision
From start-ups to the SIX Swiss Exchange – a Swiss success story
ConcePTION: tackling the unknowns of medication in pregnancy
Understanding drug-resistant TB
How do cancer cells communicate and can it help us catch them?
Proteomics and the promise of ‘enriching’ clinical trials
